SCNX

Healthcare

Scienture Holdings, Inc. · Medical - Healthcare Information Services

UQS Score — Balanced Preset
22.2
Weak

Scienture Holdings, Inc. scores 22.2/100 using the Balanced preset.

0.0
Quality
35%
11.0
Moat
30%
62.5
Growth
20%
46.0
Risk
15%

SCNX — Key Takeaways

✅ Strengths

Scienture Holdings, Inc. shows solid revenue and earnings growth trajectory

⚠️ Areas of Concern

Scienture Holdings, Inc. has below-average profitability metrics
Scienture Holdings, Inc. has limited competitive moat
Scienture Holdings, Inc. has stretched valuation metrics

SCNX — Score History

1520253035Apr 2Apr 3Apr 4Apr 5Apr 6Apr 7Apr 8
DateUQSQualityMoatGrowthRiskValueChange
Apr 8, 202622.20.011.062.546.00.00.0
Apr 7, 202622.20.011.062.546.00.00.0
Apr 6, 202622.20.011.062.546.00.00.0
Apr 5, 202622.20.011.062.546.00.0-4.0
Apr 4, 202626.20.011.062.572.80.0-1.8
Apr 3, 202628.00.011.062.585.00.0+3.7
Apr 2, 202624.30.011.043.885.00.0

SCNX — Pillar Breakdown

Quality

0.0/100 (25%)

Scienture Holdings, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.

Capital Efficiency (ROIC)Weak

How effectively capital is deployed to generate returns.

Return on EquityWeak

Profitability relative to shareholders' equity.

Operating ProfitabilityWeak

Ability to convert revenue into operating profit.

Net ProfitabilityWeak

Bottom-line profit as a share of revenue.

Gross Profit / AssetsWeak

Asset productivity — how much gross profit each dollar of assets generates.

Cash GenerationWeak

Free cash flow relative to market value.

Growth

62.5/100 (20%)

Scienture Holdings, Inc. demonstrates healthy growth trends across revenue and earnings.

Recent Revenue TrendStrong

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthWeak

Year-over-year earnings per share growth.

Forward Revenue OutlookStrong

Analyst consensus for future revenue growth.

Risk

46.0/100 (15%)

Scienture Holdings, Inc. has some risk factors including moderate leverage or solvency concerns.

Financial LeverageWeak

Debt levels relative to earnings capacity.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioStrong

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

0.0/100 (15%)

Scienture Holdings, Inc. appears expensively valued relative to its fundamentals and growth prospects.

Moat

11/100 (30%)

Scienture Holdings, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for SCNX.

Score Composition

Quality
0.0×25%0.0
Growth
62.5×20%12.5
Risk
46.0×15%6.9
Valuation
0.0×15%0.0
Moat
11.0×30%3.3
Total
22.2Weak

Unlock Full SCNX Analysis

Sign in to access detailed financial metrics, interactive price charts, custom pillar weights, 6 investor presets, and watchlist tracking.

✓ Detailed ratios✓ Price chart✓ Custom moat ratings✓ 6 investor presets✓ Watchlist
Analyze SCNX in Detail →

More Stock Analysis

How is the SCNX UQS Score Calculated?

The UQS (Unified Quality Score) for Scienture Holdings, Inc. is calculated using a proprietary 5-pillar framework with 25 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses Scienture Holdings, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether Scienture Holdings, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.